Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria.
The findings, published in the November 26…
Novel mRNA-based therapy may offer a new path to tackle antibiotic-resistant infections
